File(s) under permanent embargo
Targeting classical IL-6 signalling or IL-6 trans-signalling in depression?
Version 2 2024-05-30, 15:32
Version 1 2014-10-28, 10:36
journal contribution
posted on 2024-05-30, 15:32 authored by M Maes, G Anderson, M Kubera, Michael BerkMichael BerkTargeting classical IL-6 signalling or IL-6 trans-signalling in depression?
History
Journal
Expert opinion on therapeutic targetsVolume
18Pagination
495-512Location
London, EnglandPublisher DOI
ISSN
1472-8222eISSN
1744-7631Language
engPublication classification
C1 Refereed article in a scholarly journalCopyright notice
2014 Informa HealthcareIssue
5Publisher
Informa HealthcareUsage metrics
Categories
Keywords
antidepressantcytokinesdepressioninflammationIL-6oxidative and nitrosative stresstryptophan catabolitesScience & TechnologyLife Sciences & BiomedicinePharmacology & PharmacySOLUBLE INTERLEUKIN-6 RECEPTORSEROTONIN-IMMUNE INTERACTIONSINFLAMMATORY RESPONSE SYSTEMGUT BARRIER DYSFUNCTIONRANDOMIZED DOUBLE-BLINDPITUITARY-ADRENAL AXISNECROSIS-FACTOR-ALPHAACUTE-PHASE PROTEINSBLOOD-BRAIN-BARRIERC-REACTIVE PROTEIN920410 Mental Health110319 Psychiatry (incl Psychotherapy)111714 Mental HealthInnovation in Mental and Physical Health and Clinical TreatmentSchool of MedicineFaculty of Health
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC